194 related articles for article (PubMed ID: 28623739)
1. High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease.
Liu HH; Guo YL; Wu NQ; Zhu CG; Gao Y; Qing P; Li S; Zhao X; Zhang Y; Sun D; Liu G; Dong Q; Li JJ
Atherosclerosis; 2017 Aug; 263():104-111. PubMed ID: 28623739
[TBL] [Abstract][Full Text] [Related]
2. Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.
Dai W; Zhang Z; Zhao S
Lipids Health Dis; 2018 Dec; 17(1):273. PubMed ID: 30509306
[TBL] [Abstract][Full Text] [Related]
3. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
4. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
[TBL] [Abstract][Full Text] [Related]
5. Large HDL Subfraction But Not HDL-C Is Closely Linked With Risk Factors, Coronary Severity and Outcomes in a Cohort of Nontreated Patients With Stable Coronary Artery Disease: A Prospective Observational Study.
Li JJ; Zhang Y; Li S; Cui CJ; Zhu CG; Guo YL; Wu NQ; Xu RX; Liu G; Dong Q; Sun J
Medicine (Baltimore); 2016 Jan; 95(4):e2600. PubMed ID: 26825910
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
7. High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.
Omote K; Yokota I; Nagai T; Sakuma I; Nakagawa Y; Kamiya K; Iwata H; Miyauchi K; Ozaki Y; Hibi K; Hiro T; Fukumoto Y; Mori H; Hokimoto S; Ohashi Y; Ohtsu H; Ogawa H; Daida H; Iimuro S; Shimokawa H; Saito Y; Kimura T; Matsuzaki M; Nagai R; Anzai T
J Atheroscler Thromb; 2022 Jan; 29(1):50-68. PubMed ID: 33431716
[TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
[TBL] [Abstract][Full Text] [Related]
10. Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris.
Hirayama K; Ota T; Harada K; Shibata Y; Tatami Y; Harata S; Kawashima K; Kunimura A; Shimbo Y; Takayama Y; Kawamiya T; Yamamoto D; Osugi N; Suzuki S; Ishii H; Murohara T
Clin Ther; 2017 Feb; 39(2):279-287. PubMed ID: 28034517
[TBL] [Abstract][Full Text] [Related]
11. Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry.
Shiiba M; Zhang B; Miura SI; Ike A; Nose D; Kuwano T; Imaizumi S; Sugihara M; Iwata A; Nishikawa H; Kawamura A; Shirai K; Yasunaga S; Saku K
Heart Vessels; 2018 Feb; 33(2):102-112. PubMed ID: 28815384
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease.
Hong LF; Yan XN; Lu ZH; Fan Y; Ye F; Wu Q; Luo SH; Yang B; Li JJ
Lipids Health Dis; 2017 Jan; 16(1):7. PubMed ID: 28086966
[TBL] [Abstract][Full Text] [Related]
13. Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in type 2 diabetics: A Gensini score evaluation.
Chen J; Zhang Y; Liu J; Chen MH; Guo YL; Zhu CG; Xu RX; Dong Q; Li JJ
Diab Vasc Dis Res; 2015 Jul; 12(4):258-64. PubMed ID: 25861813
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease.
Yang SH; Du Y; Li XL; Zhang Y; Li S; Xu RX; Zhu CG; Guo YL; Wu NQ; Qing P; Gao Y; Cui CJ; Dong Q; Sun J; Li JJ
Am J Med Sci; 2017 Aug; 354(2):117-124. PubMed ID: 28864368
[TBL] [Abstract][Full Text] [Related]
15. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry.
Matsuoka Y; Ike A; Ogawa M; Gondo K; Shirai K; Sugihara M; Nose D; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Yasunaga S; Miura SI; Saku K
J Cardiol; 2018 Mar; 71(3):259-267. PubMed ID: 29129396
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.
Alber HF; Wanitschek MM; de Waha S; Ladurner A; Suessenbacher A; Dörler J; Dichtl W; Frick M; Ulmer H; Pachinger O; Weidinger F
Eur J Clin Invest; 2008 Jun; 38(6):372-80. PubMed ID: 18489399
[TBL] [Abstract][Full Text] [Related]
17. Relationship between low-density lipoprotein levels on admission and 1-year outcome in patients with acute ST-segment-elevation myocardial infarction.
Sun YJ; Li YZ; Jiang DM; Zhang B; Gao Y; Zhang ZH; Qi GX
Kaohsiung J Med Sci; 2013 Apr; 29(4):206-13. PubMed ID: 23541266
[TBL] [Abstract][Full Text] [Related]
18. Non-HDL-C is a Better Predictor for the Severity of Coronary Atherosclerosis Compared with LDL-C.
Zhang Y; Wu NQ; Li S; Zhu CG; Guo YL; Qing P; Gao Y; Li XL; Liu G; Dong Q; Li JJ
Heart Lung Circ; 2016 Oct; 25(10):975-81. PubMed ID: 27634241
[TBL] [Abstract][Full Text] [Related]
19. The relationship between coenzyme Q10 and severity of coronary artery disease.
Büyükkaya E; Evliyaoğlu O; Islamoğlu Y; Cil H; Karakaş MF; Akçay AB; Bilen P; Kurt M; Şen N; Ertas F; Mete N
Med Glas (Zenica); 2013 Aug; 10(2):229-33. PubMed ID: 23892836
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
